Restore Medical: Funding, Investors & Team (Sep 2026)
Restore Medical creates and offers a device-oriented treatment for congestive heart failure that enhances patient well-being and lowers hospital re-admission rates. Their innovative product, ContraBand, is a catheter-delivered implant placed in the pulmonary arteries to assist in treating left ventricle failure in patients with preserved right ventricle function. Established in 2016, Restore Medical is based in Or Yehuda, Israel.
Restore Medical has raised $23.0M across 1 funding round on record, the most recent a Series B of $23.0M announced in Jul 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Restore Medical Company Profile and Key Stats
Latest funding round on record: Jul 2025.
Restore Medical Funding Rounds
Restore Medical Founders and Leadership Team
No contact details are on record for this team yet.
Restore Medical Funding Compared to Other Biotechnology Startups
Restore Medical's latest round of $23.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Restore Medical in Biotechnology and Or Yehuda
Companies Similar to Restore Medical
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Restore Medical Funding FAQs
What does Restore Medical do?
Restore Medical creates and offers a device-oriented treatment for congestive heart failure that enhances patient well-being and lowers hospital re-admission rates. Their innovative product, ContraBand, is a catheter-delivered implant placed in the pulmonary arteries to assist in treating left ventricle failure in patients with preserved right ventricle function. Established in 2016, Restore Medical is based in Or Yehuda, Israel.
How much funding has Restore Medical raised?
Restore Medical has raised $23.0M across 1 round on record. The most recent is a Series B of $23.0M announced in Jul 2025.
When did Restore Medical last raise funding?
Restore Medical's most recent funding round on record is a Series B of $23.0M, announced in Jul 2025.
Who founded Restore Medical?
FundedIQ lists Elchanan Bruikheimer (Founder) at Restore Medical.
Where is Restore Medical headquartered?
Restore Medical is based in Or Yehuda, Tel Aviv, Israel.
How many employees does Restore Medical have?
Restore Medical is in the 11-50 employee band.
How does Restore Medical's funding compare to other Biotechnology startups?
Restore Medical's latest round of $23.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Restore Medical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Restore Medical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.